Technological progress in pharmaceutical research is opening new avenues for the High Throughput Screening Market. Automated screening systems and advanced analytical capabilities are helping laboratories manage increasingly complex research requirements, enabling efficient evaluation of compounds and supporting the broader drug discovery pipeline.

According to The Insight Partners, the high throughput screening market is driven by increasing research and development investment across the pharmaceutical and biotechnology industries and the introduction of technologically advanced screening products. High throughput screening uses automation and robotics to accelerate biological and biochemical testing and is widely used for assessing pharmacological targets, agonists, antagonists, receptors, and enzymes.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00041090

High Throughput Screening Market Size and Share

The high throughput screening market size is expected to increase substantially during the forecast period. The market was valued at 15,997.47 million in 2021 and is projected to reach 28,255.71 million by 2028, reflecting a CAGR of 8.5% from 2021 to 2028. North America held the largest regional share, accounting for 39.3% of the market in 2021. The United States market is projected to register a CAGR of 8.9% during the forecast period, while Asia Pacific is expected to grow at a CAGR of 9.2%.

High Throughput Screening Market Growth Drivers

Increasing investment in research and development by pharmaceutical and biotechnology companies is a major growth driver for the high throughput screening market. The development of drug pipelines for chronic diseases, including cardiovascular disorders, cancer, immunological disorders, metabolic disorders, and neurological disorders, is increasing the need to screen large chemical libraries. Automated high throughput screening systems can screen around 10,000 to 100,000 target compounds in a single day, supporting faster drug discovery and development activities.

Government and research institute investments are also supporting the adoption of HTS techniques. The report highlights the increasing number of drug targets used in drug discovery and development as another factor supporting market growth. Programs involving automated high throughput screening for toxicological examination and disease-related pathway assessment further contribute to adoption. At the same time, high screening costs, a lack of trained professionals, and complexity in assay development may restrain market growth.

High Throughput Screening Market Segmentation

The high throughput screening market is segmented by product and service, technology, application, and end user. By product and service, the market includes consumables, instruments, accessories, software, and services. Consumables accounted for the largest share at 44.9% in 2021 and are expected to witness the fastest CAGR during the forecast period.

By technology, the market is divided into cell-based assays, lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology. Cell-based assays held the largest share in 2021, while lab-on-a-chip is anticipated to register the fastest growth, with a CAGR of 10% during the forecast period. By application, the market covers drug discovery, biochemical screening, life sciences research, and other applications. Drug discovery accounted for the largest share at 60.1% in 2021 and is expected to grow at the fastest CAGR.

Top Key Players in the High Throughput Screening Market

The high throughput screening market includes several companies involved in screening technologies, products, services, and related solutions. Key players profiled in the report include Agilent Technologies Inc., Axxam S.P.A., Eurofins Scientific, Corning Incorporated, Molecular Devices LLC, Hamilton Company, Merck Group, PerkinElmer Inc., Tecan Group, and Thermo Fisher Scientific Inc. Companies are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and portfolio expansions to strengthen their presence and address demand from end users.

High Throughput Screening Market Growth and Opportunities

Growth opportunities in the high throughput screening market are associated with expanding drug discovery activities, rising R&D investment, increasing numbers of drug targets, and technological advancements. Contract research organizations are another important area of growth, with the CRO segment anticipated to register a CAGR of 9.5% during the forecast period. The report also identifies Asia Pacific as a rapidly developing regional market, supported by healthcare infrastructure development, research capabilities, chronic disease prevalence, and biotechnology-related activities.

High Throughput Screening Market Future Outlook

The high throughput screening market is expected to maintain its growth trajectory through 2028 as pharmaceutical and biotechnology companies continue using automated screening technologies in drug discovery and research. The combination of expanding R&D investment, increasing screening requirements, advanced technologies, and growing demand for efficient compound evaluation is expected to support market expansion. The market is projected to reach 28,255.71 million by 2028 from 15,997.47 million in 2021, at a CAGR of 8.5%.

The report covers North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America, along with country-level analysis. Its scope includes market sizing and forecasting, segmentation analysis, regional insights, competitive analysis, and company profiles, providing a detailed view of the high throughput screening market through 2028.

Trending Reports:

·         Glucose Monitoring Devices Market Size and Competitive Analysis by 2030

·         Hematology Analyzers And Reagents Market Analysis, Size, and Share by 2031

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
Contact Person: Ankit Mathur 
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in: Korean|German|Japanese|French|Chinese|Italian|Spanish